Research from Rockefeller University reveals that giant neurons in the brainstem, called nucleus gigantocellularis, express genes linked to nitric oxide production and blood vessel relaxation. This discovery supports their role in initiating behavior and potentially understanding psychiatric disorders like bipolar disorder and ADHD.
Researchers at Tohoku University found that whole-brain low-intensity pulsed ultrasound (LIPUS) therapy improved cognitive dysfunction in mice with vascular dementia and Alzheimer's disease. The treatment was shown to enhance blood vessel formation, nerve cell regeneration, and protein expression without serious side effects.
A recent randomized controlled trial found that consuming red raspberry drinks improved flow-mediated dilation, an established biomarker of cardiovascular disease risk. Ellagic acid and urolithin metabolites correlated with FMD improvements in some participants.
Researchers discovered bacterial aggregates behave like a thick liquid, facilitating meningococcal infection progression and highlighting the importance of type IV pili in aggregate formation. The study's findings provide new insights into the mechanisms governing disease development.
Research suggests that oxygen therapy can improve the function of blood vessels in the brains of individuals with chronic obstructive pulmonary disease (COPD), a common cause of dementia. This study found that delivering additional oxygen increased blood flow and oxygen delivery to the brain, matching its demands during activity.
Researchers have discovered a possible treatment approach for cerebral small vessel disease (SVD), the most common cause of dementia and stroke in older adults. Studies with rats showed that treating SVD can reverse changes in blood vessels in the brain associated with the condition, as well as prevent damage to brain cells.
Researchers at Boston University School of Medicine discovered that flavored electronic cigarettes contain additives that can decrease blood flow and increase inflammation in blood vessels, similar to combustible cigarettes. The study's findings suggest a potential link between flavored e-cigarette use and cardiovascular disease.
Antibodies against myeloperoxidase signal impending relapse in antineutrophil cytoplasmic antibody-associated vasculitis patients. Routine monitoring may help prevent disease flare-ups.
New research reveals that cigarette smoke directly damages muscles by reducing blood vessel numbers, impacting metabolism and activity levels. This muscle damage is a key risk factor for chronic diseases such as COPD and diabetes.
Research found a link between poorer health-related quality of life in adolescence and increased risk of cardiovascular disease. Adolescents with lower scores in social and mental well-being domains had structural changes in their retinal blood vessels, which could be indicative of future cardiovascular disease risk.
In a breakthrough study, NIH scientists identified distinct immune cell subsets that work together to repair the damaged meninges and blood vessels in mice. The research provides new insights into the recovery process after concussion and may lead to the development of targeted therapies to improve patient outcomes.
A new biomarker identified a 'window of opportunity' for cancer chemotherapy timing, optimizing the effectiveness of anti-angiogenic and anticancer drug combinations. The biomarker, CD109 expression in vascular endothelial cells, correlates with tumor cell growth and enables the visualization of proliferating blood vessels.
A Michigan State University study found unusual lipids in the retina's blood vessels, which may prevent diabetic retinopathy by strengthening the blood-retinal barrier. The discovery could lead to new treatments involving injections or eye drops.
Researchers have discovered that immune cells cause dangerous blood vessel blockage in response to fungal infections, leading to new therapeutic targets. The study's findings could lead to the development of treatments that prevent this blockage without inhibiting the immune system.
Scientists at Johns Hopkins Medicine have made significant breakthroughs in understanding the underlying biology behind pulmonary hypertension. By studying endothelial cells, they discovered that KLF15 protects these cells from damage caused by low oxygen levels, which can lead to blood vessel damage and progression of the disease.
Patients with cardiovascular disease have impaired levels of protective molecules in their blood in the morning, leading to increased risk of blood clots and heart attacks. Replenishing these molecules can improve cell behavior and reduce inflammation.
Researchers found that neural cells from schizophrenic patients produce less pro-angiogenic molecules and more anti-angiogenic proteins, impairing blood vessel formation. The study provides new insights into the causes of schizophrenia and potential therapeutic solutions.
Researchers discover a possible direct connection between disrupted circadian clocks and increased levels of ADAM17, an enzyme that promotes inflammation and stiffens blood vessel walls. This relationship could explain why poor sleep habits contribute to cardiovascular disease risk factors.
A new study found that a newly discovered gene called STEEL senses inadequate blood flow to tissues and triggers the growth of new blood vessels. This discovery could lead to advances in understanding and treating cardiovascular diseases such as heart disease and strokes.
A team of researchers from Osaka University has identified adult endothelial stem cells capable of generating fully functional blood vessels. The discovery was made by isolating a population of endothelial cells expressing the glycoprotein CD157 and testing their ability to form new blood vessels in injured mice.
A team of researchers has discovered a chemical compound that converts patient-derived stem cells into blood vessels, offering new hope for treating achromatopsia and cone-rod dystrophy. The compound, AA147, successfully directed the stem cells to develop primarily into endothelial cells that can form blood vessels.
A new interaction between proteins could provide a breakthrough in the prevention of healthy blood vessel damage. The study found that stabilizing caveolae regions prevents damage by binding protein SOCS3 with Cavin-1, maintaining healthy vascular function.
Biomedical engineers developed a miniaturized system mimicking blood vessel injury, allowing for the study of bleeding and clotting. The device replicates all aspects of blood vessel injury, including clot formation and repair, and responds to drugs and other alterations.
Researchers at Imperial College London used augmented reality to help surgeons locate and reconnect key blood vessels during reconstructive lower limb surgery. The technology overlays images of CT scans onto the patient's leg, allowing surgeons to 'see through' tissue and improve outcomes for patients.
Scientists at German Cancer Research Center have discovered a new target for anti-angiogenic tumor therapy by deleting a signaling molecule in mice, leading to delayed tumor growth and limited metastases. The receptor Tie1 plays a crucial role in angiogenesis and is overexpressed in tumors.
In diabetes, copper excess hinders angiogenesis, leading to impaired blood flow and increased risks of heart attacks and nerve death. Researchers are exploring ATP7A's therapeutic potential to restore healthy copper balance and improve vascular repair functions.
Researchers have identified a potential target for treatment to heal damaged blood vessels, which could be administered by paramedics on arrival at the scene. The study found that endotheliopathy occurs within minutes of injury and that improving the lining of blood vessels can reduce rates of organ failure.
A new study by Sanford Burnham Prebys Medical Discovery Institute identifies a crucial signaling pathway for angiogenesis, the growth of new blood vessels from pre-existing ones. The findings may improve current strategies to increase blood flow in ischemic tissues associated with atherosclerosis and diabetes.
A recent animal study suggests that heat-not-burn tobacco products may not offer cardiovascular protection. Exposure to iQOS vapor resulted in a significant decrease in blood vessel function, comparable to cigarette smoke.
Researchers at ETH Zurich have identified that cerebrospinal fluid exits the cranial cavity through lymph vessels in mice, rewriting anatomy textbooks. The study found that this pathway is responsible for flushing out unwanted substances and may offer a starting point for treating neurodegenerative diseases such as Alzheimer's.
Researchers found that a dengue virus protein disrupts the protective lining of blood vessels, leading to severe disease symptoms. The underlying mechanism appears to be disruption of glycocalyx components, paving the way for new potential treatments.
The Endocrine Society examines how diabetes damages microvascular system, causing complications such as diabetic retinopathy and kidney disease. Maintaining tight control over blood sugar levels may help reduce risk of complications, but also poses risk of hypoglycemia and cardiovascular issues.
Scientists identify protein disulfide isomerase (PDI) as a key therapeutic target to improve blood vessel health in diabetes. PDI regulates angiogenesis, wound healing and mitochondrial function, offering new potential treatments.
Researchers have identified adenosine receptor A2a as a potential target for reducing dysfunctional blood vessel development in the eye. Blocking this receptor has been shown to inhibit pathological angiogenesis and promote healthy blood vessel formation, offering new hope for treating diabetic retinopathy.
Researchers found that abnormalities in the brain's blood-brain barrier may play a critical role in schizophrenia development. This discovery could lead to novel treatment strategies targeting abnormal brain blood vessels, complementing existing treatments.
Pyroptosis, an explosive form of cell death, contributes to the high mortality rate of bloodstream infections by triggering excessive tissue injury. Caspase-11 is identified as a key enzyme in this process, making it a promising target for development of new treatments.
Scientists have discovered a new molecule that stimulates blood vessel formation, which could help treat non-healing wounds and injuries associated with diabetes. The discovery has the potential to reduce the number of limbs amputated due to diabetes, offering a cost-effective treatment option.
Researchers have created two new imaging agents that can visualize the formation of tumour-associated blood vessels and track tumour growth. These agents could provide personalized treatment options by identifying patients most likely to respond to therapies targeting new blood vessel growth, leading to more effective cancer treatment.
Researchers at NIH uncovered the first evidence of a brain lymphatic system, suggesting vessels act as a pipeline between brain and immune system. The discovery uses MRI to scan brains of healthy volunteers and confirms results in human and nonhuman primate brains.
Researchers found that preeclampsia can permanently change blood vessel function, increasing cardiovascular disease risk. Applying a drug to restore dilation response shows promise as potential treatment strategy.
Researchers have successfully bioengineered a functional lung with perfusable and healthy vasculature in an ex vivo rodent lung. This breakthrough approach selectively treats epithelium while preserving lung vasculature, addressing the organ's extreme complexity.
Researchers at IBS and KAIST found that YAP/TAZ promotes cytoskeleton remodeling and junction formation in endothelial cells, essential for normal as well as pathological angiogenesis. Overexpression of YAP/TAZ leads to excessive blood vessel growth, while removal results in vision impairment and internal bleeding.
Aged chimpanzee brains exhibit pathology similar to human Alzheimer's disease, including Aβ plaques and tau lesions. The study provides the most extensive evidence of AD brain pathology in a primate species, shedding light on the evolution and potential targets for therapeutic interventions.
Researchers suggest targeting aldosterone receptor for effective hypertension treatment in women. High aldosterone levels are linked to increased blood pressure and cardiovascular risk.
Researchers at UCSB used star ascidian to study the interaction between cells and their physical environment, finding a mechanism that allows blood vessels to shrink without impeding blood flow. This discovery has implications for understanding cellular development and metastasis in cancer.
Researchers at North Carolina State University have developed a new surgical tool using low-frequency intravascular ultrasound to break down blood clots. The tool breaks down clots into fine particles, reducing the need for high doses of blood thinners and potentially lowering treatment time.
Researchers have developed a method using 3D-printed patches infused with cells that offer a promising new approach to growing healthy blood vessels. The patches with pre-organized structure demonstrated improved results in reducing ischemia, while those without organization resulted in a disorganized network.
A new hydrogel material combined with vascular endothelial growth factor (VEGF) has been shown to enhance the survival rate of transplanted insulin-producing cells in animal models. The technology could potentially treat more patients with type 1 diabetes and reduce the need for multiple donors.
A new study reveals that blood vessels in the brainstem constrict when oxygen levels rise, unlike other parts of the body. This specialized response helps maintain proper breathing and is made possible by astrocytes releasing signaling molecules.
Researchers discovered specific genetic changes in placentas of women who gave birth to growth-restricted infants, which sabotage placental blood vessel growth and fetal nourishment. These changes can be used as a biomarker to predict normal pregnancy and newborn health.
Learning about key 'danger zones' can help plastic surgeons enhance the safety and effectiveness of facial filler procedures. The article emphasizes the importance of safe, predictable techniques to achieve optimal results with dermal fillers, particularly in areas commonly addressed by facial filler injection.
Researchers have found that a signaling molecule produced by T-cells can induce the regression of blood vessels in tumors, effectively shutting down their supply of oxygen and nutrients. This discovery could lead to improved treatment options for solid tumors using immunotherapy with T-cells.
Researchers at Osaka University have found that the breakdown of SEMA4D protein causes inflammation and disease in AAV patients. The study suggests that SEMA4D could be used as a new clinical marker to improve diagnosis accuracy.
Researchers reprogram tumor blood vessels to block tumor growth and facilitate T cell arrival, improving cancer immunotherapy efficacy. A2V therapy inhibits metastasis and promotes anti-tumor immunity, which can be enhanced by PD-1 checkpoint blockade.
A team of researchers identified the transcription factor RUNX1 as a novel therapeutic target for retinal neovascularization, a hallmark of advanced diabetic eye disease. By inhibiting RUNX1 with a small molecule drug, they achieved a 50% reduction of retinopathy in preclinical models.
White blood cells use their nuclei to exert force and insert themselves between endothelial cells, creating large holes in the blood vessel walls. This discovery sheds light on the movement of immune cells and may aid in cancer research.
Scientists have identified a molecular switch that converts skin cells into cells making up blood vessels, which could be used to repair damaged vessels in patients with heart disease. The technique boosts levels of an enzyme that keeps cells young and may circumvent the usual aging that cells undergo during culturing.
A UTA engineer has been awarded a grant to develop materials that can be used in 3-D printing to create unique new blood vessels for children with vascular defects. The goal is to overcome the challenges of current tissue-engineered blood vessels, which are fragile and cannot withstand blood pressure.
Researchers discovered that tumor blood vessels and the immune system interact, with immune cells promoting vessel normalization to improve anti-tumor therapies. This bidirectional regulation may lead to better cancer treatment outcomes when considering both vascular structure and immune response.
Researchers identified secretogranin III as a potential therapeutic target for preventing diabetic retinopathy and retinopathy of prematurity. Inhibiting this protein may reduce vision loss in both conditions.